サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1733356

自閉症スペクトラム障害の診断と治療市場：診断タイプ別、治療タイプ別、流通チャネル別、地域別、2026～2032年

Autism Spectrum Disorder Diagnosis And Therapeutics Market By Diagnosis Type, By Treatment Type, By Distribution Channel, And Region For 2026-2032

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
自閉症スペクトラム障害の診断と治療市場：診断タイプ別、治療タイプ別、流通チャネル別、地域別、2026～2032年
出版日: 2025年05月13日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

自閉症スペクトラム障害の診断と治療市場の評価-2026～2032年

自閉症スペクトラム障害（ASD）の診断と治療市場は、認知度と診断方法の向上とともに拡大しています。神経画像検査と遺伝子検査の進歩により、早期発見と個別診断が改善され、より的を絞った治療が成功するようになります。これにより、市場規模は2024年に380億米ドルを突破し、2032年には約540億米ドルに達する見込みです。

行動療法、薬剤治療、革新的な介入はすべて、ASDの治療戦略の変化の一部です。ASD患者の生活の質（QOL）と機能的結果を改善すること、早期介入と個別化治療が重視されるようになり、市場は拡大しています。自閉症スペクトラム障害の診断と治療に対する需要の高まりが、2024～2032年のCAGR 4.49%での市場の成長を可能にしています。

自閉症スペクトラム障害の診断と治療市場定義/概要

自閉症スペクトラム障害（ASD）は、社会性、コミュニケーション、行動上の困難によって区別される神経発達疾患群です。行動評価と発達歴検査は一般的な診断ツールです。

症状を管理し、生活の質を高めるために、ASD治療には行動療法、教育的取り組み、状況によっては薬剤療法が含まれます。個々の治療計画が作成されます。

ASDの将来的な改善には、個別化医療、診断技術の強化、より効果的な管理と支援のための行動療法、遺伝学的手法、薬剤療法を組み合わせた統合療法が含まれると考えられます。

良心の高まりと早期介入プログラム障害の開始は自閉症スペクトラム障害の診断と治療市場の成長を促進するか？

意識の高まりと早期介入プログラム障害の実施が、自閉症スペクトラム（ASD）診断と治療市場を大きく押し上げると予測されます。意識の高まりは早期診断を強化し、より迅速で成功する治療をもたらします。

早期介入プログラムは、早い時期に症状に対処し、サポートを提供することで結果を改善します。このような積極的な戦略は、診断ツールや治療ソリューションの需要を高め、産業を前進させています。さらに、新規治療法の研究開発も促進され、市場拡大の原動力となっています。

自閉症の病因に関する限られた知識は、自閉症スペクトラム障害診断と治療市場の妨げになるか？

自閉症スペクトラム障害（ASD）診断と治療産業は、自閉症の病因に関する理解不足により苦境に立たされる可能性があります。自閉症の根本的な原因に関する十分な知識がないため、的を絞った医薬品や成功する介入策の創造が妨げられます。この曖昧さは、研究開発と新薬の上市を妨げる可能性があります。

さらに、診断の正確さや治療の調整にも影響を及ぼし、その結果、最適な治療結果が得られないこともあります。しかし、遺伝学と神経生物学における現在の調査と進歩は、こうした障害を克服し、産業の拡大を推進する可能性があります。

目次

第1章 世界の自閉症スペクトラム障害の診断と治療市場の導入

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 世界の自閉症スペクトラム障害の診断と治療市場展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 自閉症スペクトラム障害の診断と治療の世界市場：診断タイプ別

  • 概要
  • 臨床診断
  • 遺伝子検査
  • 神経画像診断

第6章 自閉症スペクトラム障害の診断と治療法の世界市場：治療タイプ別

  • 概要
  • 行動療法
  • 薬理学的介入
  • 言語療法
  • 作業療法
  • 社会技能訓練

第7章 自閉症スペクトラム障害の診断と治療法の世界市場：流通チャネル別

  • 概要
  • 小児の自閉症
  • 青年期と成人期の自閉症

第8章 自閉症スペクトラム障害の診断と治療の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • その他
    • ラテンアメリカ
    • 中東・アフリカ

第9章 世界の自閉症スペクトラム障害の診断と治療市場の競合情勢

  • 概要
  • 各社の市場ランキング
  • 主要開発戦略

第10章 企業プロファイル

  • PaxMedica
  • Yamo Pharmaceuticals
  • Otsuka Pharmaceutical Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Q BioMed Inc.
  • Curemark, LLC
  • Zynerba Pharmaceuticals, Inc.
  • Axial Therapeutics
  • Novartis AG
  • STALICLA

第11章 主要開発

  • 製品上市/開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第12章 付録

  • 関連調査
目次
Product Code: 69405

Autism Spectrum Disorder Diagnosis And Therapeutics Market Valuation - 2026-2032

The market for autism spectrum disorder (ASD) diagnosis and treatment is growing as awareness and diagnostic methods improve. Advances in neuroimaging and genetic testing improve early detection and individualized diagnosis, resulting in more targeted and successful therapies. This is likely to enable the market size surpass USD 38 Billion valued in 2024 to reach a valuation of around USD 54 Billion by 2032.

Behavioral therapy, pharmaceutical treatments and innovative interventions are all part of the changing therapeutic strategy for ASD. The market is growing due to an increasing emphasis on improving quality of life and functional results for people with ASD, as well as early intervention and individualized treatments. The rising demand for Autism Spectrum Disorder Diagnosis and Therapeutics is enabling the market grow at a CAGR of 4.49% from 2024 to 2032.

Autism Spectrum Disorder Diagnosis And Therapeutics Market: Definition/ Overview

Autism Spectrum Disorder (ASD) is a group of neurodevelopmental diseases distinguished by social, communicative and behavioral difficulties. Behavioral assessments and developmental history examinations are common diagnostic tools.

To manage symptoms and enhance quality of life, ASD treatments include behavioral therapies, educational initiatives and, in certain situations, medication. Individual treatment plans are developed.

Future improvements in ASD are likely to include personalized medicine, enhanced diagnostic technologies and integrated therapies that combine behavioral, genetic and pharmaceutical methods for more effective management and support.

Will Increasing Conscience and Launching Early Intervention Programs Boost the Autism Spectrum Disorder Diagnosis And Therapeutics Market Growth?

Growing awareness and the implementation of early intervention programs are predicted to greatly boost the autism spectrum disorder (ASD) diagnostic and therapies market. increasing awareness enhances early diagnosis, resulting in more prompt and successful treatment.

Early intervention programs improve outcomes by addressing symptoms and offering support at an early age. This proactive strategy boosts demand for diagnostic tools and therapeutic solutions, propelling the industry forward. Furthermore, it promotes research and development of novel treatments, which fuels market expansion.

Will Limited Knowledge about the Etiology of Autism Hamper the Autism Spectrum Disorder Diagnosis And Therapeutics Market?

The Autism Spectrum Disorder (ASD) diagnosis and therapies industry may suffer due to a lack of understanding of the etiology of autism. The absence of a thorough knowledge of autism's underlying causes hampers the creation of targeted medicines and successful interventions. This ambiguity can impede research development and the launch of novel medicines.

Furthermore, it may have an impact on diagnosis accuracy and treatment tailoring, resulting in less-than-optimal outcomes. However, current research and advances in genetics and neurobiology may overcome these obstacles and propel industry expansion.

Category-Wise Acumens

Will Widespread Use and Established Procedures Drive the Clinical Diagnosis Segment?

The clinical diagnostic segment of the autism spectrum disorders market is predicted to grow due to extensive use and established processes. Established diagnostic techniques, such as complete behavioral assessments and developmental history evaluations, provide early and accurate diagnosis, allowing for timely intervention.

The increasing use of standardized diagnostic instruments and methods improves consistency and reliability, promoting growth in the clinical diagnosis segment. Furthermore, rising awareness and greater access to diagnostic services contribute to increasing demand and market growth.

Will Effectiveness in Improving Behavioral and Developmental Outcomes Drive the Behavioral Therapies Segment?

The success of behavioral therapies in improving behavioral and developmental outcomes is a major driver of the segment's expansion. These therapies, such as Applied Behavior Analysis (ABA), are well-known for improving abilities and managing symptoms in people with autism spectrum disorder (ASD). Their systematic, evidence-based approach significantly improves communication, social connections and daily functioning. This effectiveness promotes widespread acceptance and continuing investment in behavioral therapies, hence extending the segment. As a result, it remains the most popular therapy option in the ASD market.

Country/Region-wise Acumens

Will High Awareness of Autism Drive the Market in North America?

Autism awareness will have a big impact on the North American market. Increasing public and professional understanding of autism spectrum diseases leads to earlier diagnosis and intervention, hence increasing demand for diagnostic tools and therapeutic solutions. increasing awareness also encourages lobbying and financing for research, which leads to better treatment options and support services.

As a result, North America benefits from a well-developed healthcare infrastructure and strong market growth, bolstering its dominant position in the ASD diagnostic and treatment market.

Will Increasing Funding for Autism Research Drive the Market in Asia Pacific Region?

Increasing funding for autism research is predicted to drive growth in the Asia-Pacific area. increasing financial support enables breakthroughs in diagnostic technologies, therapeutic interventions and novel treatment approaches. This financing also supports research collaborations and enhances healthcare infrastructure, resulting in increasing autism awareness and early diagnosis.

As research progresses, more medicines and interventions will become available, driving market expansion. increasing funding also supports training and education for healthcare workers, broadening the reach and impact of autism-related services in the region.

Competitive Landscape

The Autism Spectrum Disorder Diagnosis And Therapeutics Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the Autism Spectrum Disorder Diagnosis And Therapeutics Market include:

PaxMedica

Yamo Pharmaceuticals

Otsuka Pharmaceutical Co., Ltd.

Hoffmann-La Roche Ltd

Q BioMed Inc.

Curemark, LLC

Zynerba Pharmaceuticals, Inc.

Axial Therapeutics

Novartis AG

STALICLA

Latest Developments

In August 2022, Bened Life launched Neuralli, its first gut-brain medicinal probiotic. Neuralli uses L. plantarum, a proprietary probiotic strain that promotes mental health and supports neurological diseases such as autism spectrum disorder and Parkinson's Disease.

In March 2022, STALICLA announced that it has successfully completed phase 1b trials for STP1, their lead Drug candidate. This clinical data prepares the way for the first application of precision medicine discovery. STALICLA's platform is designed for those with autism spectrum disorders.

Autism Spectrum Disorder Diagnosis And Therapeutics Market, By Category

  • Diagnosis Type:
  • Clinical Diagnosis
  • Genetic Testing
  • Neuroimaging
  • Treatment Type:
  • Behavioral Therapies
  • Pharmacological Interventions
  • Speech and Language Therapy
  • Occupational Therapy
  • Social Skills Training
  • Distribution Channel:
  • Pediatric Autism Market
  • Adolescent and Adult Autism Market
  • Region:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSIS AND THERAPEUTICS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSIS AND THERAPEUTICS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSIS AND THERAPEUTICS MARKET, BY DIAGNOSIS TYPE

  • 5.1 Overview
  • 5.2 Clinical Diagnosis
  • 5.3 Genetic Testing
  • 5.4 Neuroimaging

6 GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSIS AND THERAPEUTICS MARKET, BY TREATMENT TYPE

  • 6.1 Overview
  • 6.2 Behavioral Therapies
  • 6.3 Pharmacological Interventions
  • 6.4 Speech and Language Therapy
  • 6.5 Occupational Therapy
  • 6.6 Social Skills Training

7 GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSIS AND THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

  • 7.1 Overview
  • 7.2 Pediatric Autism Market
  • 7.3 Adolescent and Adult Autism Market

8 GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSIS AND THERAPEUTICS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSIS AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 PaxMedica
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Yamo Pharmaceuticals
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Otsuka Pharmaceutical Co., Ltd.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 F. Hoffmann-La Roche Ltd
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Q BioMed Inc.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Curemark, LLC
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Zynerba Pharmaceuticals, Inc.
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Axial Therapeutics
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Novartis AG
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 STALICLA
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research